Global Melanocortin Receptor 4 Market Research Report 2024

Report ID: 1969940 | Published Date: Jan 2025 | No. of Page: 86 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Melanocortin Receptor 4 Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Bremelanotide
        1.2.3 Corticotropin
        1.2.4 Cosyntropin
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Melanocortin Receptor 4 Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Metabolic Disorder
        1.3.3 Women's Health
        1.3.4 Genito Urinary System
        1.3.5 Infection Disease
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Melanocortin Receptor 4 Market Perspective (2017-2028)
    2.2 Melanocortin Receptor 4 Growth Trends by Region
        2.2.1 Melanocortin Receptor 4 Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Melanocortin Receptor 4 Historic Market Size by Region (2017-2022)
        2.2.3 Melanocortin Receptor 4 Forecasted Market Size by Region (2023-2028)
    2.3 Melanocortin Receptor 4 Market Dynamics
        2.3.1 Melanocortin Receptor 4 Industry Trends
        2.3.2 Melanocortin Receptor 4 Market Drivers
        2.3.3 Melanocortin Receptor 4 Market Challenges
        2.3.4 Melanocortin Receptor 4 Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Melanocortin Receptor 4 Players by Revenue
        3.1.1 Global Top Melanocortin Receptor 4 Players by Revenue (2017-2022)
        3.1.2 Global Melanocortin Receptor 4 Revenue Market Share by Players (2017-2022)
    3.2 Global Melanocortin Receptor 4 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Melanocortin Receptor 4 Revenue
    3.4 Global Melanocortin Receptor 4 Market Concentration Ratio
        3.4.1 Global Melanocortin Receptor 4 Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Melanocortin Receptor 4 Revenue in 2021
    3.5 Melanocortin Receptor 4 Key Players Head office and Area Served
    3.6 Key Players Melanocortin Receptor 4 Product Solution and Service
    3.7 Date of Enter into Melanocortin Receptor 4 Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Melanocortin Receptor 4 Breakdown Data by Type
    4.1 Global Melanocortin Receptor 4 Historic Market Size by Type (2017-2022)
    4.2 Global Melanocortin Receptor 4 Forecasted Market Size by Type (2023-2028)
5 Melanocortin Receptor 4 Breakdown Data by Application
    5.1 Global Melanocortin Receptor 4 Historic Market Size by Application (2017-2022)
    5.2 Global Melanocortin Receptor 4 Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Melanocortin Receptor 4 Market Size (2017-2028)
    6.2 North America Melanocortin Receptor 4 Market Size by Country (2017-2022)
    6.3 North America Melanocortin Receptor 4 Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Melanocortin Receptor 4 Market Size (2017-2028)
    7.2 Europe Melanocortin Receptor 4 Market Size by Country (2017-2022)
    7.3 Europe Melanocortin Receptor 4 Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Melanocortin Receptor 4 Market Size (2017-2028)
    8.2 Asia-Pacific Melanocortin Receptor 4 Market Size by Country (2017-2022)
    8.3 Asia-Pacific Melanocortin Receptor 4 Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Melanocortin Receptor 4 Market Size (2017-2028)
    9.2 Latin America Melanocortin Receptor 4 Market Size by Country (2017-2022)
    9.3 Latin America Melanocortin Receptor 4 Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Melanocortin Receptor 4 Market Size (2017-2028)
    10.2 Middle East & Africa Melanocortin Receptor 4 Market Size by Country (2017-2022)
    10.3 Middle East & Africa Melanocortin Receptor 4 Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 AstraZeneca Plc
        11.1.1 AstraZeneca Plc Company Detail
        11.1.2 AstraZeneca Plc Business Overview
        11.1.3 AstraZeneca Plc Melanocortin Receptor 4 Introduction
        11.1.4 AstraZeneca Plc Revenue in Melanocortin Receptor 4 Business (2017-2022)
        11.1.5 AstraZeneca Plc Recent Development
    11.2 Mallinckrodt Plc
        11.2.1 Mallinckrodt Plc Company Detail
        11.2.2 Mallinckrodt Plc Business Overview
        11.2.3 Mallinckrodt Plc Melanocortin Receptor 4 Introduction
        11.2.4 Mallinckrodt Plc Revenue in Melanocortin Receptor 4 Business (2017-2022)
        11.2.5 Mallinckrodt Plc Recent Development
    11.3 Obexia AG
        11.3.1 Obexia AG Company Detail
        11.3.2 Obexia AG Business Overview
        11.3.3 Obexia AG Melanocortin Receptor 4 Introduction
        11.3.4 Obexia AG Revenue in Melanocortin Receptor 4 Business (2017-2022)
        11.3.5 Obexia AG Recent Development
    11.4 Palatin Technologies, Inc.
        11.4.1 Palatin Technologies, Inc. Company Detail
        11.4.2 Palatin Technologies, Inc. Business Overview
        11.4.3 Palatin Technologies, Inc. Melanocortin Receptor 4 Introduction
        11.4.4 Palatin Technologies, Inc. Revenue in Melanocortin Receptor 4 Business (2017-2022)
        11.4.5 Palatin Technologies, Inc. Recent Development
    11.5 Pfizer Inc.
        11.5.1 Pfizer Inc. Company Detail
        11.5.2 Pfizer Inc. Business Overview
        11.5.3 Pfizer Inc. Melanocortin Receptor 4 Introduction
        11.5.4 Pfizer Inc. Revenue in Melanocortin Receptor 4 Business (2017-2022)
        11.5.5 Pfizer Inc. Recent Development
    11.6 Retrophin Inc.
        11.6.1 Retrophin Inc. Company Detail
        11.6.2 Retrophin Inc. Business Overview
        11.6.3 Retrophin Inc. Melanocortin Receptor 4 Introduction
        11.6.4 Retrophin Inc. Revenue in Melanocortin Receptor 4 Business (2017-2022)
        11.6.5 Retrophin Inc. Recent Development
    11.7 Rhythm Pharmaceuticals, Inc.
        11.7.1 Rhythm Pharmaceuticals, Inc. Company Detail
        11.7.2 Rhythm Pharmaceuticals, Inc. Business Overview
        11.7.3 Rhythm Pharmaceuticals, Inc. Melanocortin Receptor 4 Introduction
        11.7.4 Rhythm Pharmaceuticals, Inc. Revenue in Melanocortin Receptor 4 Business (2017-2022)
        11.7.5 Rhythm Pharmaceuticals, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Melanocortin Receptor 4 Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Bremelanotide
    Table 3. Key Players of Corticotropin
    Table 4. Key Players of Cosyntropin
    Table 5. Key Players of Others
    Table 6. Global Melanocortin Receptor 4 Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Melanocortin Receptor 4 Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Melanocortin Receptor 4 Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Melanocortin Receptor 4 Market Share by Region (2017-2022)
    Table 10. Global Melanocortin Receptor 4 Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Melanocortin Receptor 4 Market Share by Region (2023-2028)
    Table 12. Melanocortin Receptor 4 Market Trends
    Table 13. Melanocortin Receptor 4 Market Drivers
    Table 14. Melanocortin Receptor 4 Market Challenges
    Table 15. Melanocortin Receptor 4 Market Restraints
    Table 16. Global Melanocortin Receptor 4 Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Melanocortin Receptor 4 Market Share by Players (2017-2022)
    Table 18. Global Top Melanocortin Receptor 4 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melanocortin Receptor 4 as of 2021)
    Table 19. Ranking of Global Top Melanocortin Receptor 4 Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Melanocortin Receptor 4 Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Melanocortin Receptor 4 Product Solution and Service
    Table 23. Date of Enter into Melanocortin Receptor 4 Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Melanocortin Receptor 4 Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Melanocortin Receptor 4 Revenue Market Share by Type (2017-2022)
    Table 27. Global Melanocortin Receptor 4 Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Melanocortin Receptor 4 Revenue Market Share by Type (2023-2028)
    Table 29. Global Melanocortin Receptor 4 Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Melanocortin Receptor 4 Revenue Market Share by Application (2017-2022)
    Table 31. Global Melanocortin Receptor 4 Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Melanocortin Receptor 4 Revenue Market Share by Application (2023-2028)
    Table 33. North America Melanocortin Receptor 4 Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Melanocortin Receptor 4 Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Melanocortin Receptor 4 Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Melanocortin Receptor 4 Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Melanocortin Receptor 4 Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Melanocortin Receptor 4 Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Melanocortin Receptor 4 Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Melanocortin Receptor 4 Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Melanocortin Receptor 4 Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Melanocortin Receptor 4 Market Size by Country (2023-2028) & (US$ Million)
    Table 43. AstraZeneca Plc Company Detail
    Table 44. AstraZeneca Plc Business Overview
    Table 45. AstraZeneca Plc Melanocortin Receptor 4 Product
    Table 46. AstraZeneca Plc Revenue in Melanocortin Receptor 4 Business (2017-2022) & (US$ Million)
    Table 47. AstraZeneca Plc Recent Development
    Table 48. Mallinckrodt Plc Company Detail
    Table 49. Mallinckrodt Plc Business Overview
    Table 50. Mallinckrodt Plc Melanocortin Receptor 4 Product
    Table 51. Mallinckrodt Plc Revenue in Melanocortin Receptor 4 Business (2017-2022) & (US$ Million)
    Table 52. Mallinckrodt Plc Recent Development
    Table 53. Obexia AG Company Detail
    Table 54. Obexia AG Business Overview
    Table 55. Obexia AG Melanocortin Receptor 4 Product
    Table 56. Obexia AG Revenue in Melanocortin Receptor 4 Business (2017-2022) & (US$ Million)
    Table 57. Obexia AG Recent Development
    Table 58. Palatin Technologies, Inc. Company Detail
    Table 59. Palatin Technologies, Inc. Business Overview
    Table 60. Palatin Technologies, Inc. Melanocortin Receptor 4 Product
    Table 61. Palatin Technologies, Inc. Revenue in Melanocortin Receptor 4 Business (2017-2022) & (US$ Million)
    Table 62. Palatin Technologies, Inc. Recent Development
    Table 63. Pfizer Inc. Company Detail
    Table 64. Pfizer Inc. Business Overview
    Table 65. Pfizer Inc. Melanocortin Receptor 4 Product
    Table 66. Pfizer Inc. Revenue in Melanocortin Receptor 4 Business (2017-2022) & (US$ Million)
    Table 67. Pfizer Inc. Recent Development
    Table 68. Retrophin Inc. Company Detail
    Table 69. Retrophin Inc. Business Overview
    Table 70. Retrophin Inc. Melanocortin Receptor 4 Product
    Table 71. Retrophin Inc. Revenue in Melanocortin Receptor 4 Business (2017-2022) & (US$ Million)
    Table 72. Retrophin Inc. Recent Development
    Table 73. Rhythm Pharmaceuticals, Inc. Company Detail
    Table 74. Rhythm Pharmaceuticals, Inc. Business Overview
    Table 75. Rhythm Pharmaceuticals, Inc. Melanocortin Receptor 4 Product
    Table 76. Rhythm Pharmaceuticals, Inc. Revenue in Melanocortin Receptor 4 Business (2017-2022) & (US$ Million)
    Table 77. Rhythm Pharmaceuticals, Inc. Recent Development
    Table 78. Research Programs/Design for This Report
    Table 79. Key Data Information from Secondary Sources
    Table 80. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Melanocortin Receptor 4 Market Share by Type: 2021 VS 2028
    Figure 2. Bremelanotide Features
    Figure 3. Corticotropin Features
    Figure 4. Cosyntropin Features
    Figure 5. Others Features
    Figure 6. Global Melanocortin Receptor 4 Market Share by Application in 2021 & 2028
    Figure 7. Metabolic Disorder Case Studies
    Figure 8. Women's Health Case Studies
    Figure 9. Genito Urinary System Case Studies
    Figure 10. Infection Disease Case Studies
    Figure 11. Others Case Studies
    Figure 12. Melanocortin Receptor 4 Report Years Considered
    Figure 13. Global Melanocortin Receptor 4 Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Melanocortin Receptor 4 Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Melanocortin Receptor 4 Market Share by Region: 2021 VS 2028
    Figure 16. Global Melanocortin Receptor 4 Market Share by Players in 2021
    Figure 17. Global Top Melanocortin Receptor 4 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melanocortin Receptor 4 as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Melanocortin Receptor 4 Revenue in 2021
    Figure 19. North America Melanocortin Receptor 4 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. North America Melanocortin Receptor 4 Market Share by Country (2017-2028)
    Figure 21. United States Melanocortin Receptor 4 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Melanocortin Receptor 4 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Melanocortin Receptor 4 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Melanocortin Receptor 4 Market Share by Country (2017-2028)
    Figure 25. Germany Melanocortin Receptor 4 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Melanocortin Receptor 4 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Melanocortin Receptor 4 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Melanocortin Receptor 4 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Melanocortin Receptor 4 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Melanocortin Receptor 4 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Melanocortin Receptor 4 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Melanocortin Receptor 4 Market Share by Region (2017-2028)
    Figure 33. China Melanocortin Receptor 4 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Japan Melanocortin Receptor 4 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. South Korea Melanocortin Receptor 4 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Southeast Asia Melanocortin Receptor 4 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. India Melanocortin Receptor 4 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Australia Melanocortin Receptor 4 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Melanocortin Receptor 4 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Melanocortin Receptor 4 Market Share by Country (2017-2028)
    Figure 41. Mexico Melanocortin Receptor 4 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Brazil Melanocortin Receptor 4 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Melanocortin Receptor 4 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Melanocortin Receptor 4 Market Share by Country (2017-2028)
    Figure 45. Turkey Melanocortin Receptor 4 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Saudi Arabia Melanocortin Receptor 4 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. AstraZeneca Plc Revenue Growth Rate in Melanocortin Receptor 4 Business (2017-2022)
    Figure 48. Mallinckrodt Plc Revenue Growth Rate in Melanocortin Receptor 4 Business (2017-2022)
    Figure 49. Obexia AG Revenue Growth Rate in Melanocortin Receptor 4 Business (2017-2022)
    Figure 50. Palatin Technologies, Inc. Revenue Growth Rate in Melanocortin Receptor 4 Business (2017-2022)
    Figure 51. Pfizer Inc. Revenue Growth Rate in Melanocortin Receptor 4 Business (2017-2022)
    Figure 52. Retrophin Inc. Revenue Growth Rate in Melanocortin Receptor 4 Business (2017-2022)
    Figure 53. Rhythm Pharmaceuticals, Inc. Revenue Growth Rate in Melanocortin Receptor 4 Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca Plc
Mallinckrodt Plc
Obexia AG
Palatin Technologies, Inc.
Pfizer Inc.
Retrophin Inc.
Rhythm Pharmaceuticals, Inc.
Frequently Asked Questions
Melanocortin Receptor 4 report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Melanocortin Receptor 4 report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Melanocortin Receptor 4 report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports